- This event has passed.
OMG! Responding to a Cyberattack on Your Law Firm
March 23 @ 12:00 pm - 2:00 pmFree
Approved by The Florida Bar for 2.5 hours of General CLE credit, including 2.5 hours of Technology CLE credit.
Sponsored by The Florida Bar Board Technology Committee, and LegalFuel: The Practice Resource Center of The Florida Bar.
This webinar will consist of two mock exercises. The first exercise will be a mock response to a cyberattack on a law firm without a response plan in place. The second exercise will be a mock response on a law firm with a response plan in place.
Issues to be discussed include:
- Organizing a response
- How to restore business operations
- Protecting client and third party data
- Whether reporting of the incident is required under applicable ethics rules and state and federal law
- To pay or not to pay a ransom demand
- Benefits of cyber insurance
Free (Limited Spots)
Franklin Zemel is a partner at Saul Ewing Arnstein & Lehr, LLP and graduated from the University of Miami School of Law in 1989. He is a Certified Information Privacy Professional and his practice includes Privacy and Cybersecurity Law, Religious Land Use and First Amendment law, Complex Business Litigation and Appellate Law. Franklin represents large and small businesses, manufacturers, and religious entities in South Florida and has several significant reported cases. In addition to his state bar admissions, Franklin is admitted to practice in U.S. District Courts in the Southern and Middle Districts of Florida, the Southern District of New York and Western District of Michigan.
Steven Teppler, CDPSE, is a partner at Mandelbaum Barrett, and Chair of the Firm’s Privacy and Cybersecurity practice group, as well as our Chief Cybersecurity Legal Officer. Steven focuses his practice on pro-active, preventive and remedial cybersecurity and privacy work for clients, as well as advising on potential class action and mass tort liability arising from security vulnerabilities and code defects in technology-enabled devices and services. Steven is an ISACA Certified Data Privacy Solutions Engineer(CDPSE), who has been at the forefront of cybersecurity, data privacy and eDiscovery matters since 2000, and has extensive technology, blockchain and class action litigation experience. He also has deep hands-on experience stemming from his work to secure six cryptography patents, and his role leading a content authentication technology startup, and teaches Electronic Discovery and Cybersecurity Law at Nova Southeastern University’s Shepard Broad College of Law.
John Giantsidis is the President of CyberActa, a boutique consultancy empowering medical device, digital health, and pharmaceutical companies in their regulatory, cybersecurity, privacy, data, and commercialization endeavors. With deep regulatory and technology background, a broad range of experience over a 27-year career, and a sharp focus on tackling emerging risks, John affords his clients with strategic yet pragmatic perspectives on addressing critical risks in a business-focused and impactful manner. John is a Cyber Aux with the U.S. Marine Corps, a member of Cybersecurity & Infrastructure Security Agency (“CISA”) Healthcare POC, an advisor to the National Telecommunications and Information Administration (“NTIA”) in its Software Component Transparency efforts, and a past voting member of Association for the Advancement of Medical Instrumentation (“AAMI”) in Health IT Security matters. He holds a Bachelor of Science degree from Clark University, a Juris Doctor from the University of New Hampshire School of Law, and a Master of Engineering in Cybersecurity Policy and Compliance from The George Washington University. He frequently writes and speaks on a broad range of current issues facing the MedTech and life sciences industries such as building privacy and cybersecurity in medical devices, the evolving regulatory landscape in this rapid pace of technology-driven healthcare, and addressing the challenges of product development, generation of evidence, proof of value, implementation, and adoption of novel medical and health technologies.